Log in to save to my catalogue

Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxor...

Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxor...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4301465

Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells

About this item

Full title

Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells

Publisher

England: BioMed Central

Journal title

BMC cancer, 2014-12, Vol.14 (1), p.955-955, Article 955

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Cancer-associated fibroblasts and high mobility group box 1 (HMGB1) protein have been suggested to mediate cancer progression and chemotherapy resistance. The role of such fibroblasts in HMGB1 production in breast cancer is unclear. This study aimed to investigate the effects of cancer-associated fibroblasts on HMGB1 expression in breast cancer cel...

Alternative Titles

Full title

Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4301465

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4301465

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/1471-2407-14-955

How to access this item